Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2014; 03(04): 206-208
DOI: 10.4103/2278-330X.142964
LEUKEMIAS : Original Article

Frequency of 11q23/MLL gene rearrangement in Egyptian childhood acute myeloblastic leukemia: Biologic and clinical significance

Adel Abdelhaleim Hagag
Department of Pediatrics, Pediatric Hematology-Oncology Unit
,
Shebl S. Shebl
Department of Pediatrics, Pediatric Hematology-Oncology Unit
,
Nabih H. El-Fadaly
Department of Clinical Pathology, Tanta University, Egypt
› Author Affiliations Source of Support: Nill.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Background: Molecular cytogenetic abnormalities involving 11q23 are among the most common cytogenetic abnormalities in acute myeloid leukemia (AML) patients. Aim of the work: we aimed to evaluate the frequency of MLL/AF9 fusion gene in de novo AML patients, its impact on clinical features, and its prognostic significance. Patients and Methods: Twenty-eight children patients with AML and 20 healthy controls were subjected to complete clinical examination and laboratory investigations including, complete hemogram and bone marrow (BM) examination. Diagnosis was based on FAB morphologic and immunophenotypic criteria. Detection of (MLL/AF9) fusion gene was assessed by dual color fluorescent in situ hybridization (FISH). Follow-up were carried out clinically and by blast count in BM, and response to therapy to detect the outcome of the disease. Results: The incidence of MLL-fusion gene MLL/AF9 in AML cases was about (6/28) (21%). Four patients with MLL/AF9 fusion gene were newly diagnosed, two cases were at relapse and no patient at remission showed positivity. As regard the clinical outcome, five out of six MLL positive cases died, three of them during induction and two during relapse. The FAB AML subtypes with MLL/AF9 fusion were one M2, three M4, and two M5. Conclusion: MLL-fusion gene MLL/AF9 was found in about 21% of studied AML patients when assessed by FISH technique and this is of high clinical relevance as most of these abnormalities have been associated with poor prognosis.

Key words

Acute myelobastic leukemia - 11q23/MLL gene. Dual color FISH.


Publication History

Article published online:
31 December 2020

© 2014. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. https://creativecommons.org/licenses/by-nc-nd/4.0/.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Liu Y, He P, Liu F, Shi L, Zhu H, Zhao J, et al. Prognostic significance of NPM1 mutations in acute myeloid leukemia: A meta-analysis. Mol Clin Oncol 2014;2:275-81.
  • 2 Tasian SK, Pollard JA, Aplenc R. Molecular therapeutic approaches for pediatric acute myeloid leukemia. Front Oncol 2014;4:55.
  • 3 Mrózek K, Heinonen K, Bloomfield CD. Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol 2001;14:19-47.
  • 4 Ohlsson E, Hasemann MS, Willer A, Lauridsen FK, Rapin N, Jendholm J, et al. Initiation of MLL-rearranged AML is dependent on C/EBPa. J Exp Med 2014;211:5-13.
  • 5 Ibrahim S, Estey EH, Pierce S, Glassman A, Keating M, O′Brien S, et al. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses. Am J Clin Pathol 2000;114:793-7.
  • 6 Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: Results of an international retrospective study. Blood 2009;114:2489-96.
  • 7 Lanzkowsky PH. Leukemias. In: Lanzkowsky P, editor. Manual of Pediatric Hematology and Oncology. 4th ed., Vol. 17. Nek, Madrid, London: Churchill Livingstone; 2011. p. 518-66.
  • 8 Verhaak RG, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W, et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): Association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 2005;106:3747-54.
  • 9 Chen YM, Liu TF, Ruan M, Zou Y, Chen XJ, Guo Y, et al. Prognosis and chromosomal abnormalities in 79 children with t (8;21) acute myeloid leukemia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2009;31:542-6.
  • 10 Hemenway CS, de Erkenez AC, Gould GC. The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in t (9;11)(p22;q23) acute leukemias. Oncogene 2001;20:3798-805.
  • 11 He YX, Xue YQ, Wang HY, Shao XJ, Pan JL, Xu J, et al. Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2012;29:677-82.
  • 12 Launay E, Henry C, Meyer C, Chappé C, Taque S, Boulland ML, et al. MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t (11;22)(q23;q11). Leuk Lymphoma 2014;55:662-7.
  • 13 Strissel PL, Strick R, Tomek RJ, Roe BA, Rowley JD, Zeleznik-Le NJ. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum Mol Genet 2000;9:1671-9.
  • 14 Muñoz L, Nomdedéu JF, Villamor N, Guardia R, Colomer D, Ribera JM, et al. Acute myeloid leukemia with MLL rearrangements: Clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Leukemia 2003;17:76-82.
  • 15 Tuborgh A1, Meyer C, Marschalek R, Preiss B, Hasle H, Kjeldsen E. Complex three-way translocation involving MLL, ELL, RREB1, and CMAHP genes in an infant with acute myeloid leukemia and t (6;19;11)(p22.2;p13.1;q23.3). Cytogenet Genome Res 2013;141:7-15.
  • 16 Wang T, Gao W, Liu HX, Teng W, Ren J, Wang CF, et al. Acute myeloid leukemia with t (11;22) (q23;q11.2): Two cases report and literature review. Zhonghua Xue Ye Xue Za Zhi 2013;34:1028-31.
  • 17 Morerio C, Acquila M, Rosanda C, Rapella A, Tassano E, Micalizzi C, et al. t (9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia. Leuk Res 2005;29:467-70.